Veru (VERU) EBITDA Margin (QoQ) (2012 - 2024)
Veru (VERU) EBITDA Margin (QoQ) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Veru | 59.70 Mn | 33.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 15,859.00 |
| Sep 30, 2024 | 15,339.00 |
| Jun 30, 2024 | -3,752.00 |
| Mar 31, 2024 | 12,909.00 |
| Dec 31, 2023 | -15,652.00 |
| Sep 30, 2023 | 19,941.00 |
| Jun 30, 2023 | 11,143.00 |
| Mar 31, 2023 | 97,099.00 |
| Dec 31, 2022 | 24,240.00 |
| Sep 30, 2022 | -150,866.00 |
| Jun 30, 2022 | -13,698.00 |
| Mar 31, 2022 | 228,400.00 |
| Dec 31, 2021 | -236,234.00 |
| Sep 30, 2021 | 19,736.00 |
| Jun 30, 2021 | -19,829.00 |
| Mar 31, 2021 | -318,771.00 |
| Dec 31, 2020 | 313,947.00 |
| Sep 30, 2020 | 86,138.00 |
| Jun 30, 2020 | -76,028.00 |
| Mar 31, 2020 | -4,703.00 |